atezolizumab based treatment | avelumab based treatment | nivolumab based treatment | pembrolizumab based treatment | Immune checkpoint association | |||||
atezolizumab alone | atezolizumab plus bevacizumab | avelumab plus axitinib | nivolumab alone | nivolumab plus cabozantinib | pembrolizumab alone | pembrolizumab plus axitinib | pembrolizumab plus lenvatinib | nivolumab plus ipilimumab |